Literature DB >> 26617129

Next-generation sequencing-based 5' rapid amplification of cDNA ends for alternative promoters.

Bambarendage P U Perera1, Joomyeong Kim2.   

Abstract

Mammalian genomes contain many unknown alternative first exons and promoters. Thus, we have modified the existing 5'RACE (5' rapid amplification of cDNA ends) approach into a next-generation sequencing (NGS)-based new protocol that can identify these alternative promoters. This protocol has incorporated two main ideas: (i) 5'RACE starting from the known second exons of genes and (ii) NGS-based sequencing of the subsequent cDNA products. This protocol also provides a bioinformatics strategy that processes the sequence reads from NGS runs. This protocol has successfully identified several alternative promoters for an imprinted gene, PEG3. Overall, this NGS-based 5'RACE protocol is a sensitive and reliable method for detecting low-abundant transcripts and promoters.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5′RACE; Alternative promoters; NGS; Peg3

Mesh:

Substances:

Year:  2015        PMID: 26617129     DOI: 10.1016/j.ab.2015.11.006

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Phylogenetic and Epigenetic Footprinting of the Putative Enhancers of the Peg3 Domain.

Authors:  Joomyeong Kim; An Ye
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

2.  Circular RNA identified from Peg3 and Igf2r.

Authors:  Bambarendage P U Perera; Subash Ghimire; Joomyeong Kim
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

3.  Enhancer-driven alternative promoters of imprinted genes.

Authors:  Joomyeong Kim; Bambarendage P U Perera; Subash Ghimire
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

4.  Alternative promoters of Peg3 with maternal specificity.

Authors:  Bambarendage P U Perera; Joomyeong Kim
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.